Studies from our laboratory demonstrate that lymphatic pump treatment (LPT) significantly decreases solid tumor formation in the lungs of rats with tumors. Therefore, the focus of these studies was to determine the immune mechanisms, both locally and systemically, responsible for this protection. The most significant finding of this study is that LPT exerts a tissue specific response in the lung. LPT significantly increased leukocyte numbers, including those of GALT-derived lymphocytes in the lung of tumor-bearing rats. Furthermore, LPT enhanced cytokine production by pulmonary leukocytes in vitro. Preliminary findings suggest that LPT does not promote lymphangiogenesis and metastasis during tumor development. Our results provide early experimental support for the use of LPT as an adjunctive therapy in patients with cancer.
|Advisor:||Hodge, Lisa M.|
|Commitee:||Jones, Harlan P., Mathew, Porunelloor A.|
|School:||University of North Texas Health Science Center at Fort Worth|
|Department:||Microbiology and Immunology|
|School Location:||United States -- Texas|
|Source:||MAI 49/05M, Masters Abstracts International|
|Keywords:||Immunity, Lymphatic pump treatment, Madb106, Osteopathic manipulation|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be